The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Director/PDMR Shareholding - Options Grant

25 Nov 2020 07:00

RNS Number : 3734G
Parity Group PLC
25 November 2020
 

25 November 2020

 

Parity Group plc ("Parity" or the "Company")

Grant of Options to Directors/PDMRs

 

The Board of Parity (AIM:PTY), the technology focussed professional services business, announces that it has awarded Michael Johns, Chief Financial Officer, options over 2,000,000 ordinary shares of 2 pence each in the Company ("the Share Options"). The Share Options were granted on 24 November 2020 and represent approximately 1.9% of the Company's current issued share capital.

 

The Share Options each have an exercise price, calculated in accordance with the rules of the Parity Group 2019 EMI Options Plan, of 7.88 pence, being the closing mid-market price per ordinary share on 23 November 2020.

 

The Share Options will vest after 3 years and are subject to the following performance conditions:

 

· One third of each individual grant of Share Options will be exercisable if the share price achieves or exceeds 12.0 pence for a period of at least five consecutive trading days at any time during the vesting period;

· One third of each individual grant of Share Options will be exercisable if the share price achieves or exceeds 15.0 pence for a period of at least five consecutive trading days at any time during the vesting period; and

· One third of each individual grant of Share Options will be exercisable if the share price achieves or exceeds 18.0 pence for a period of at least five consecutive trading days at any time during the vesting period.

 

 

 

Contacts:

Parity Group plc www.parity.net

Matthew Bayfield, CEO 0208 171 1729

 

WH Ireland Limited www.whirelandcb.com

Mike Coe / Chris Savidge 0207 220 1666

 

Donhead Consultants

David Beck +44 7836 293383

 

 

 

 

 

 

The notifications below, made in accordance with the EU Market Abuse Regulation, provide further details in relation to the grant of the Share Options to the PDMRs:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Michael Johns

2

 

Reason for the notification

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Parity Group plc

b)

 

LEI

213800YEHAYBJ63OHB38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 2p each

 

GB00B1235860

b)

 

Nature of the transaction

 

Grant of options to subscribe for new ordinary shares under the Company's 2019 EMI Option Plan.

c)

 

Price(s) and volume(s)

 

Option Price(s)

 

Volume(s)

7.88p

2,000,000

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

- Price

 

 

 

2,000,000

 

£157,600.00

 

e)

 

Date of the transaction

24 November 2020

f)

 

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGQWGUPUGAC

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.